Clinical Trial Update: Novel Endovascular Access Trial (NEAT) [NA]

View source ↗

Summary

This clinical trial update reports the completion of the Novel Endovascular Access Trial (NEAT) sponsored by C. R. Bard for chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• NEAT Endovascular Access Device

Snippet

Sponsor: C. R. Bard | Conditions: Chronic Kidney Disease | NA | Status: COMPLETED